5Henter U, Elinder G, Ost A. Diagunostic guidelines for Hemophagoeytic lymphohistioeytosis. Semin Oncol, 1991, 18:29- 33.
6Imashuku S. Clinical features and treatment strategies of Epstein- Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002.44:259-272.
7Yamashita N, Kimura H, Morishima T. Virological aspects of Epstein-Barr virus infections. Acta Med Okayama, 2005, 59 : 239 -246.
8Kasahara Y, Yaehie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV- associated hemophagocytic lymphohistocytosis and chronic active EBV infection. Blood, 2001, 98: 1882-1888.
9Henderson S, Huen D, Rowe M, et al. Epstein-Barr virus encoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA, 1993, 90: 8479-8483.
10Henter JI, Home A, Aricá M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2007,48 : 124-131.
